Running contract for inj. nivolumab 40 mg in vial packing.

Running contract for inj. tislelizumab 100 mg in vial packing (tevimbra).

Inj. meropenem 1000 mg + tazobactum 125 mg in vial packing

Inj tirzepatide 2.5 mg,inj tirzepatide 5 mg,inj tirzepatide7. 5 mg,inj tirzepatide 10 mg,tab acalabrutinib 100 mg,tab niraparib 100 mg,inj insulin aspart analogue rapid acting 100 iuperml 3 ml pfs,inj tislelizumab 100 mg 10 ml vial

1) carboplatin inj 150 mg vial & 2) carboplatin inj 450 mg vial

1) cisplatin inj 50 mg vial, 2) cisplatin inj 10 mg vial, 3) cyclophosphamide inj 500 mg vial & 4) cyclophosphamide 50 mg tab

Inj cisatracurium 20 mg per 10ml vial of 10 ml,inj sugammadex 100 mg per ml vial of 2 ml,inj dexmedetomidin 200 mcg per 2 ml,inj intralipid 20 persent amino acid 20 persent lipid 100 ml,inj succinylcholine chloride 50 mg per ml vial of 10 ml,inj mephentermine 300 mg per 10 ml vial

Atezolizumab inj 1200 mg vial

Clarithromycin inj 500 mg vial

Inj. somatropin i.p 4 mg/12 iu (recombinant human growth hormone) in vial packing